Prenatal onset spinal muscular atrophy
- PMID: 10700541
- DOI: 10.1053/ejpn.1999.0184
Prenatal onset spinal muscular atrophy
Abstract
Five patients with severe spinal muscular atrophy (SMA) type I, all of whom presented with reduced fetal movements in utero, severe weakness at birth, and short survival time were assessed to attempt to determine whether their phenotype could be explained by their genotype. The diagnosis was confirmed by clinical, electrophysiological and histopathological features. Polymerase chain reaction assays were used to define the molecular diagnosis. A gene-dosage assay was used to assess the quantity of centromeric survival motor neuron gene (SMNc) present. In all cases the telomeric survival motor neuron gene (SMNt) was absent. The SMNc gene was present but in reduced copy number compared with a control group of children with less severe type I SMA, so may be important in determining severity. In the differential diagnosis of reduced fetal movements, SMA should be considered. The clinical classification may in future be clarified by molecular genetic findings.
Copyright 1999 European Paediatric Neurology Society.
Comment in
-
Very severe spinal muscular atrophy (SMA type 0): an expanding clinical phenotype.Eur J Paediatr Neurol. 1999;3(2):49-51. doi: 10.1053/ejpn.1999.0181. Eur J Paediatr Neurol. 1999. PMID: 10700538
Similar articles
-
Very severe spinal muscular atrophy (SMA type 0): an expanding clinical phenotype.Eur J Paediatr Neurol. 1999;3(2):49-51. doi: 10.1053/ejpn.1999.0181. Eur J Paediatr Neurol. 1999. PMID: 10700538
-
[Very severe spinal muscular atrophy--type 0. A cause of congenital multiple arthrogryposis].Ugeskr Laeger. 2001 Oct 8;163(41):5679-80. Ugeskr Laeger. 2001. PMID: 11665473 Danish.
-
Clinical and molecular genetic features of congenital spinal muscular atrophy.Ann Neurol. 1996 Nov;40(5):731-8. doi: 10.1002/ana.410400509. Ann Neurol. 1996. PMID: 8957014
-
Clinical and molecular diagnosis of spinal muscular atrophy.Neurol India. 2002 Jun;50(2):117-22. Neurol India. 2002. PMID: 12134171 Review.
-
Clinical trials in spinal muscular atrophy.Curr Opin Pediatr. 2007 Dec;19(6):675-9. doi: 10.1097/MOP.0b013e3282f1884c. Curr Opin Pediatr. 2007. PMID: 18025935 Review.
Cited by
-
Spinal Muscular Atrophy.Neurol Clin. 2015 Nov;33(4):831-46. doi: 10.1016/j.ncl.2015.07.004. Neurol Clin. 2015. PMID: 26515624 Free PMC article. Review.
-
Spinal Muscular Atrophy: The Past, Present, and Future of Diagnosis and Treatment.Int J Mol Sci. 2023 Jul 26;24(15):11939. doi: 10.3390/ijms241511939. Int J Mol Sci. 2023. PMID: 37569314 Free PMC article. Review.
-
Spinal muscular atrophy: diagnosis and management in a new therapeutic era.Muscle Nerve. 2015 Feb;51(2):157-67. doi: 10.1002/mus.24497. Epub 2014 Dec 16. Muscle Nerve. 2015. PMID: 25346245 Free PMC article. Review.
-
Clinical perspectives: Treating spinal muscular atrophy.Mol Ther. 2024 Aug 7;32(8):2489-2504. doi: 10.1016/j.ymthe.2024.06.020. Epub 2024 Jun 18. Mol Ther. 2024. PMID: 38894541 Review.
-
Exploring the Influence of Concurrent Nutritional Therapy on Children with Spinal Muscular Atrophy Receiving Nusinersen Treatment.Children (Basel). 2024 Jul 23;11(8):886. doi: 10.3390/children11080886. Children (Basel). 2024. PMID: 39201821 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources